NeuMoDx Molecular Inc., which offers high-throughput molecular diagnostics platforms for hospitals and reference laboratories, is submitting the coronavirus assay for Emergency Use Authorization (EUA) in the US.
The guidance allows some labs to start using COVID-19 laboratory-developed tests while awaiting US Food and Drug Administration approval under the EUA. The FDA requires that EUA applications be submitted...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?